AbbVie Inc. (NYSE:ABBV) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. Berenberg Grows More Confident in AbbVie (ABBV) on Skyrizi and Rinvoq Momentum On January 20, Berenberg raised its price target on AbbVie Inc. (NYSE:ABBV) to $275 from$270, while keeping a Buy rating on the stock. The firm said it is feeling more confident about AbbVie’s outlook, especially after lifting its forecasts for Skyrizi and Rinvoq, calling their growth trajectory “exceptional.” In other news, on Jan ...